Enhanced Standard Care: Clinical Trials

9 trials of Enhanced Standard Care, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 recruiting. 7 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 4, Recruiting 3
Phase 21Completed 1
Phase 31Completed 1

Follow Enhanced Standard Care: new trials by email Literature Review of Enhanced Standard Care trials Research Report on Enhanced Standard Care

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
Cancer Education, Meaning-Centered Counseling, Peer Support - Cancer, Survivorship
Not applicableRecruitingMemorial Sloan Kettering Cancer Center642026-02-272026-11-06
Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk
Installation of Heartfelt Device, Enhanced Standard care, Questionnaires - Heart Failure
Not applicableRecruitingHeartfelt Technologies3002025-12-182026-07-28
Brief Transdiagnostic Treatment for Anxiety Disorders and Post-traumatic Stress Disorder (PTSD) in South Africa
False Safety Behavioral Elimination Treatment (FSET), Enhanced Standard Care - Anxiety Disorders, Post-traumatic Stress Disorder
Not applicableRecruitingMassachusetts General Hospital602024-05-082024-07-17
SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
Sarcoidosis Patient Assessment and Resource Companion App, Enhanced Standard Care - Sarcoidosis, Fatigue
Not applicableCompletedMedical University of South Carolina502022-02-232025-04-06
The Support, Educate, Empower (SEE) Program
Personalized Glaucoma Coaching, Enhanced Standard care - Glaucoma
Not applicableCompletedUniversity of Michigan2362021-04-272025-11-03
Multimodal Sexual Dysfunction Intervention In HCT
Enhanced Standard Care, Multimodal Intervention to Address Sexual Dysfunction - Hematopoietic Stem Cell Transplantation, Hematologic Diseases
Not applicableCompletedMassachusetts General Hospital2302019-02-012026-04-06
Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors
Mobile App + enhanced standard care, Enhanced Standard Care - Other Cancer
Not applicableCompletedMassachusetts General Hospital602019-02-012026-09-24
Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix
Enhanced standard care, Intensive lifestyle intervention - Obesity, Diet Therapy
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1232013-03-282026-10-08
A Lifestyle Change Program to Prevent Type 2 Diabetes
Enhanced standard care, Lifestyle counseling - Prediabetes
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)582005-09-012012-05-07

Conditions studied

Anxiety Disorders (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fatigue (1)  ·  Glaucoma (1)  ·  Heart Failure (1)  ·  Hematologic Diseases (1)  ·  Medication Adherence (1)  ·  Neoplasms (1)  ·  Obesity (1)  ·  Prediabetic State (1)  ·  Sarcoidosis (1)  ·  Sexual Dysfunction, Physiological (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Weight Gain (1)

Sponsors

Massachusetts General Hospital (3)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  Heartfelt Technologies (1)  ·  Medical University of South Carolina (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  University of Michigan (1)

Countries

United States (6)  ·  South Africa (1)  ·  United Kingdom (1)

Top investigators

Areej El-Jawahri, MD (1)  ·  Areej El-Jawhri, MD (1)  ·  Florence Lui, PhD (1)  ·  Mary A Hoskin, R.D. (1)  ·  Paula Newman-Casey, MD MS (1)  ·  Robin Whittemore, PhD (1)  ·  Suzanne Winter, MS (1)

Results publications

PMID 40490014, PMID 19092550, PMID 26708836, PMID 30230252, PMID 33238176, PMID 40769685, PMID 40839263, PMID 41029405, PMID 41746659

NIH funding

K01TW012180 (1), R01EY031337 (1), R21EB025525 (1)